✦ LIBER ✦

Successful pregnancy in a liver transplant recipient treated with lamivudine for de novo hepatitis

✍ Scribed by Massimiliano Loreno; Patrizio Bo; Marco Senzolo; Umberto Cillo; Nikolai Naoumov; Patrizia Burra

Publisher: Springer
Year: 2004
Tongue: English
Weight: 229 KB
Volume: 17
Category: Article
ISSN: 0934-0874
DOI: 10.1007/s00147-004-0785-5

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

The clinical course of transplantation-a

The clinical course of transplantation-associated de novo hepatitis B infection in the liver transplant recipient

✍ Douglas, D D ;Rakela, J ;Wright, T L ;Krom, R A ;Wiesner, R H 📂 Article 📅 1997 🏛 Wiley (John Wiley & Sons) 🌐 English ⚖ 159 KB 👁 1 views

Transmission of hepatitis B infection from hepatitis B surface antigen (HBsAg)-negative antibody to hepatitis B core (anti-HBc)-positive liver donors has been previously described. The longterm outcome of these transplant-associated de novo hepatitis B patients has not been well described and may a

Disappearance of hepatitis B virus core

Disappearance of hepatitis B virus core deletion mutants and successful combined kidney/liver transplantation in a patient treated with lamivudine

✍ Helga Meisel; Petra Preikschat; Petra Reinke; Berthold Hocher; Klemens Budde; W. 📂 Article 📅 1999 🏛 Springer 🌐 English ⚖ 175 KB

Anti-erythropoietin antibody–mediated pu

Anti-erythropoietin antibody–mediated pure red cell aplasia in a living donor liver transplant recipient treated for hepatitis C virus

✍ Jordan M. Schecter; J. Gregory Mears; Bachir Alobeid; Paul J. Gaglio 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 91 KB 👁 1 views

After liver transplantation, reinfection of the newly engrafted liver with hepatitis C virus is essentially universal in patients who are viremic at the time of transplantation. Treatment with interferon preparations with or without ribavirin is recommended in patients with marked histologic injury;

De novo hepatocellular carcinoma in a li

De novo hepatocellular carcinoma in a liver graft with sustained hepatitis C virus clearance after living donor liver transplantation

✍ Kazutoyo Morita; Akinobu Taketomi; Yuji Soejima; Toru Ikegami; Takasuke Fukuhara 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 276 KB 👁 1 views

The occurrence of de novo hepatocellular carcinoma (HCC) after liver transplantation (LT) for advanced HCCs has been extremely limited. In this article, a case of de novo HCC in a liver graft with sustained hepatitis C virus clearance after living donor liver transplantation (LDLT) for multiple HCCs

Antibodies against cytokeratin 8/18 in a

Antibodies against cytokeratin 8/18 in a patient with de novo autoimmune hepatitis after living-donor liver transplantation

✍ Ayano Inui; Tsuyoshi Sogo; Haruki Komatsu; Hiroshi Miyakawa; Tomoo Fujisawa 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 83 KB 👁 1 views

Graft dysfunction mimicking autoimmune hepatitis rarely develops after liver transplantation for nonautoimmune disease. The mechanism(s) and causes of de novo autoimmune hepatitis are unknown. We examined autoantibodies serially in a patient with de novo autoimmune hepatitis and in patients without

Increased incidence of early de novo can

Increased incidence of early de novo cancer in liver graft recipients treated with cyclosporine: An association with C2 monitoring and recipient age

✍ Angela S. W. Tjon; Jerome Sint Nicolaas; Jaap Kwekkeboom; Robert A. de Man; Geer 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 304 KB 👁 1 views

The goal of this study was to determine the risk factors for de novo cancer after liver transplantation (LTx). Retrospective analyses were performed in 385 LTx patients who underwent transplantation between 1986 and 2007. In total, 50 (13.0%) recipients developed de novo malignancy. The cumulative i